BioCentury | Oct 24, 2020
Finance

Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris

...Biotech AG has raised a further CHF12.7 million ($13.9 million) in seed financing led by Pureos Bioventures...
BioCentury | Sep 25, 2020
Finance

With inaugural fund, Pureos looks to build up Swiss biotech ecosystem

...By Virginia Li Nearly half of Pureos Bioventures’ first fund, which closed this week at $170 million...
...$170 million, could be headed towards Swiss drug developers.The firm began investing its global BB Pureos Bioventures...
BioCentury | Sep 18, 2020
Finance

Lava’s $83M series C exemplifies evolution of Novo Ventures’ investing

...Lava’s series C, which had participation from fellow new investors Redmile Group, Ysios Capital and BB Pureos Bioventures...
BioCentury | Jul 29, 2020
Finance

With €27M at launch, Vico revives Prosensa oligonucleotide programs, aims to edit RNA for Rett

...firm were co-leader Kurma Partners as well as Pontifax, Droia Genetic Disease, Polaris Partners and Pureos Bioventures...
BioCentury | Jun 12, 2020
Finance

June 11 Quick Takes: Biotech swept up in sell-off; plus Simcere, Lantern, Cue Health, C2i, BaseLaunch, Sanofi-Cathay and 4BIO

...detection of treatment failure or disease recurrence. Pureos invests in Basel incubator Swiss VC BB Pureos Bioventures...
...an undisclosed investment in the firm’s second therapeutics-focused fund. BioCentury Staff Simcere Pharmaceutical Group Lantern Pharma Inc. Cue Health Inc. Pureos Bioventures Sanofi Cathay...
BioCentury | Jan 9, 2020
Financial News

Jan. 8 Financial Quick Takes: Intra-Cellular raises $295M; plus venture rounds for nference, Eyevensys, Transcenta, Airway, Progentec

...Bpifrance, CapDecisif and Inserm Transfert, as well as new investors Global Health Sciences Fund and Pureos BioVentures...
BioCentury | Jul 16, 2019
Finance

As it preps Phase III kidney trial on its own, AM-Pharma raises €116M series C

...investor Forbion Capital Partners and existing investors Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures...
BioCentury | Apr 30, 2019
Finance

Why liver disease newco Alentis is aiming for one of largest Swiss A rounds

...raised CHF12.5 million ($12.3 million) in a series A round co-led by BioMedPartners and BB Pureos Bioventures...
Items per page:
1 - 8 of 8
BioCentury | Oct 24, 2020
Finance

Oct. 23 Quick Takes: RA Capital’s $461M new fund; plus venture rounds for Sirnaomics, 3D Medicines, Zhaoke, Orbus, Araris

...Biotech AG has raised a further CHF12.7 million ($13.9 million) in seed financing led by Pureos Bioventures...
BioCentury | Sep 25, 2020
Finance

With inaugural fund, Pureos looks to build up Swiss biotech ecosystem

...By Virginia Li Nearly half of Pureos Bioventures’ first fund, which closed this week at $170 million...
...$170 million, could be headed towards Swiss drug developers.The firm began investing its global BB Pureos Bioventures...
BioCentury | Sep 18, 2020
Finance

Lava’s $83M series C exemplifies evolution of Novo Ventures’ investing

...Lava’s series C, which had participation from fellow new investors Redmile Group, Ysios Capital and BB Pureos Bioventures...
BioCentury | Jul 29, 2020
Finance

With €27M at launch, Vico revives Prosensa oligonucleotide programs, aims to edit RNA for Rett

...firm were co-leader Kurma Partners as well as Pontifax, Droia Genetic Disease, Polaris Partners and Pureos Bioventures...
BioCentury | Jun 12, 2020
Finance

June 11 Quick Takes: Biotech swept up in sell-off; plus Simcere, Lantern, Cue Health, C2i, BaseLaunch, Sanofi-Cathay and 4BIO

...detection of treatment failure or disease recurrence. Pureos invests in Basel incubator Swiss VC BB Pureos Bioventures...
...an undisclosed investment in the firm’s second therapeutics-focused fund. BioCentury Staff Simcere Pharmaceutical Group Lantern Pharma Inc. Cue Health Inc. Pureos Bioventures Sanofi Cathay...
BioCentury | Jan 9, 2020
Financial News

Jan. 8 Financial Quick Takes: Intra-Cellular raises $295M; plus venture rounds for nference, Eyevensys, Transcenta, Airway, Progentec

...Bpifrance, CapDecisif and Inserm Transfert, as well as new investors Global Health Sciences Fund and Pureos BioVentures...
BioCentury | Jul 16, 2019
Finance

As it preps Phase III kidney trial on its own, AM-Pharma raises €116M series C

...investor Forbion Capital Partners and existing investors Ysios Capital, Kurma Partners, ID Invest Partners, BB Pureos Bioventures...
BioCentury | Apr 30, 2019
Finance

Why liver disease newco Alentis is aiming for one of largest Swiss A rounds

...raised CHF12.5 million ($12.3 million) in a series A round co-led by BioMedPartners and BB Pureos Bioventures...
Items per page:
1 - 8 of 8